BRIEF-Alpha Cognition Inc - On Track And Plans To Release Data From Alpha-1062 Pivotal Trial During Q2 Of 2022
BRIEF-Alpha Cognition Inc - On Track And Plans To Release Data From Alpha-1062 Pivotal Trial During Q2 Of 2022
简要-Alpha Cognition Inc-正在进行中，并计划在2022年第二季度发布Alpha-1062关键试验的数据
* ALPHA COGNITION INC - Q1 2022 NET LOSS WAS $2.7 MILLION, OR A NET LOSS OF $0.04 PER SHAREMay 31 (Reuters) - Alpha Cognition Inc ACOG.V :
路透5月31日电-Alpha Cognition Inc ACOG.V：
* ALPHA COGNITION INC - ON TRACK AND PLANS TO RELEASE DATA FROM ALPHA-1062 PIVOTAL TRIAL DURING Q2 OF 2022
*阿尔法认知公司-正在进行中，并计划在2022年第二季度发布阿尔法-1062关键试验的数据
* ALPHA COGNITION INC - PLANS TO MEET WITH FDA FOR ALPHA-1062 INTRANASAL FOR MTBI DURING Q3 OF 2022
*阿尔法认知公司-计划在2022年第三季度就阿尔法-1062鼻腔MTBI与FDA会面
* ALPHA COGNITION INC - Q1 2022 NET LOSS WAS $2.7 MILLION, OR A NET LOSS OF $0.04 PER SHARE
*阿尔法认知公司-2022年第一季度净亏损270万美元，或每股净亏损0.04美元
* ALPHA COGNITION INC - CASH, CASH EQUIVALENTS AS OF MARCH 31, 2022, WERE $9.1 MILLION
*阿尔法认知公司-截至2022年3月31日的现金、现金等价物为910万美元
Source text for Eikon: ID:nBw2kCFj7a Further company coverage: ACOG.V
Eikon的源文本：ID：nBw2kCFj7a进一步的公司报道：ACOG.V